Organic Active Ingredients TRIZ Cases

Tetraarsenic hexoxide crystalline polymorph A overcomes the blood-brain barrier to inhibit brain cancer cell proliferation while reducing systemic side effects.

A multi-ingredient composition combines dihydromyricetin and N-acetyl cysteine to target physiological factors contributing to hangovers.

Assessing epithelial and mesenchymal biomarkers predicts tumor cell sensitivity to EGFR kinase inhibitors, resolving trial-and-error treatment risks.

Electrostatic adhesion anchors antibiotics to collagen dressings, disrupting biofilms and accelerating healing without systemic drugs.

Segmented silyl protection and alkylation of 10-deacetylbaccatin III reduces synthesis time from 109 hours while eliminating chromatographic purification.

Substituted pyridyl piperidine compounds inhibit the Wnt pathway while reducing hepatic microsomal intrinsic clearance to improve pharmacokinetic profiles.

Heterocyclic carboxylic acid ester derivatives inhibit trypsin and enteropeptidase, resolving side effects from conventional diabetes treatments.

Specific androgen receptor modulators diminish receptor activity through targeted molecular structures.

Urea modifications at the 16th position of amphotericin B improve water solubility while reducing nephrotoxicity and hepatotoxicity.

An excipient-based formulation enables low-temperature medicant vaporization, preserving chemical structure and ensuring precise dosing.

Cis-configured imidazo benzamides enhance GPR142 agonist activity and lower blood glucose levels by optimizing molecular structure for improved efficacy.

Bioreversible groups neutralize anionic charges on polynucleotides, enabling cellular uptake without cytotoxic cationic lipid carriers.

Nanocrystal production of fluticasone propionate resolves the trade-off between high therapeutic concentration and adverse intraocular pressure.

FSTL1 polypeptides act as biological mediators to restore cellular signaling, accelerating wound closure in diabetic patients.

Treating immune cells with modulating agents during expansion maintains persistence and potency by preventing unwanted differentiation.

Mangiferin aglycone crystal form I achieves high purity through controlled crystallization in water and alcohol mixtures.

A prodrug linker uses electron-withdrawing groups to accelerate thiol-mediated cleavage of disulfide bonds.

Formula I compounds activate NPRA to mimic natriuretic peptides, bypassing short half-lives of natural hormones.

One-pot formamide reaction converts ester intermediate to apixaban, reducing synthetic steps and eliminating toxic solvents for industrial scale.

Genotyping identifies GPAM variants to tailor inhibitor dosing, resolving treatment effectiveness versus personalization complexity.

Cyclic caloric restriction sensitizes breast cancer cells to antiestrogens, overcoming therapy resistance while protecting healthy tissue.

Solubilized estradiol in medium chain oil within a soft gel dosage form enhances vaginal tissue absorption while minimizing discharge.

P2RX7 modulators overcome treatment resistance in high PD-L1 patients by restoring functional T cell responses and reducing immunosuppressive infiltration.

Quantitative reverse transcriptase polymerase chain reaction measures specific biomarker ratios to distinguish T-cell from B-cell lymphomas and grade severity.

Oil-in-water emulsions stabilize allantoin against room temperature degradation, ensuring long-term effectiveness for treating inflammatory skin conditions.

Targeting the cytokine directly avoids receptor binding issues, reducing secondary effects while alleviating psoriatic phenotypes.

Selective PI3K delta inhibitors overcome corticosteroid insensitivity in asthma and COPD patients.

Polyglutamated antifolates in liposomes enhance intracellular retention and efficacy while reducing toxicity to normal healthy cells.

Dual-action compounds combine mu-opioid agonism with sigma-1 antagonism to mitigate tolerance and side effects.

A CRISPR system delivered via bacteriophage selectively reduces pathogenic bacteria in the bladder cancer microbiome.

Replacing sodium deoxycholate with polysorbate 80 eliminates tissue necrosis and edema while maintaining injectable water solubility.

Optimized fermentation parameters yield levans with controlled molecular weights, resolving the trade-off between high productivity and purification difficulty.

NAPA compounds inhibit early viral replication by blocking cell entry, reducing drug resistance and toxicity.

Substituted urea derivatives inhibit FLT3 and FLT3-ITD kinases, addressing the lack of effective treatments for acute myeloid leukemia.

Engineered AAV capsid serotypes target specific central nervous system cells, resolving the trade-off between widespread distribution and cellular specificity.

Brominated pyrrole-2-aminoimidazole alkaloids inhibit HIV-1 replication while maintaining reduced cytotoxicity against host cells.

Administering a specific ratio of marine peptides and fish nucleotides prior to meals reduces postprandial glucose spikes while improving insulin resistance.

Propylene glycol monocaprylate and polyoxyl castor oil dissolve deuterated bradykinin antagonist, preventing precipitation to enable systemic exposure.

Polyoxyl lipid nanomicelles maintain high temperature stability while enabling effective anterior and posterior eye tissue distribution.

Amorphous isoquinolinyl triazolone complexes with cyclodextrin resolve low aqueous solubility and enhance oral bioavailability.

Liposomal mRNA encapsulation enables sustained GAA protein production, addressing progressive muscle weakness and cardiomyopathy.

Sub-stoichiometric hydroxypropyl beta cyclodextrin in the capsular wall reduces hygroscopy and protects active ingredients from degradation.

Structural optimization of N6022 into a thiazolone derivative overcomes low oral bioavailability and fast metabolism to treat diabetic vascular complications.

A drug delivery device uses a pre-assembled cartridge and ratchet driver to mechanically discharge pharmaceuticals through a perforator.

Cyclobutyl ester modifications accelerate metabolic half-life while maintaining high antiviral potency against hepatitis C virus genotypes.

Characterized polymorphic Eluxadoline forms resolve trade-offs between dissolution profiles and shelf-life for irritable bowel syndrome treatments.

IL-33 antagonists target the specific signaling pathway to reduce extracellular matrix accumulation in fibrotic diseases.

Lactic acid bacteria-derived double-stranded RNA promotes interleukin 12 and interferon beta production, avoiding viral infection risks.

Modified antisense compounds degrade Tau mRNA, lowering neurotoxic protein concentrations for Alzheimer's treatment.

A film-coated granule uses a porous substance to absorb plasticizer and lower the polymer glass transition point for compact dry coating.

Iron chelator modulation of HIF-1alpha levels shifts therapy from symptomatic management to active neural regeneration for neurodegenerative diseases.

Combining lutein esters with ashwagandha extract enhances cognitive abilities through synergistic ingredient interaction.

Segmented carbohydrate profiles provide balanced energy without excess calories while supporting calm behavior and skin health.

Adding TGF-beta to culture media increases effector cell yield while suppressing regulatory T cell formation.

Spore-forming Bacillus coagulans survives stomach acid to improve nutrient uptake and muscle development.

Dry powder amino acid formulation masks bitterness using sucralose and xanthan gum excipients.

Modifying substituents on the xanthine core creates potent compounds that overcome the lack of selective MRGPRX4 agents for wound healing and pain relief.

Segmented diltiazem granules with controlled-release membranes stabilize plasma concentrations over 24 hours, reducing first-pass metabolism impact.

Steroid administration resolves post-birth inflammation in chimeric animals by suppressing immune rejection of donor tissues.

HP-beta-CD and surfactant solubilize tropicamide at neutral pH, resolving ocular discomfort caused by acidic formulations.

Periodic pulsed rifaximin regimens maintain therapeutic durability while minimizing cumulative side effects in irritable bowel syndrome treatment.

A prednisolone acetate oral suspension uses a thickening agent to maintain uniform particle distribution in the vehicle.

Radiolabeled DNA origami nanostructures improve renal excretory function and reduce tubular damage in acute kidney injury models.

Inhibiting CDK19 expression reduces tumor mass and metastasis while improving survival outcomes in triple-negative breast cancer.

Segmenting anticancer mechanisms into EGF and telomerase inhibition reduces toxicity while maintaining efficacy against drug-resistant carcinomas.

A biodegradable hydrogel ocular insert releases dexamethasone into the tear film for continuous anti-inflammatory action.

Integrating an enteric polymer into the capsule shell formulation eliminates complex spray coating steps, reducing manufacturing defects and process time.

Specific azacycle substitution at position 2 enhances inhibitory activity against casein kinase 1 epsilon and delta while managing molecular complexity.

Oligooxopiperazines mimic helix αB to disrupt the E6-p300 interaction and reactivate tumor suppressor p53 in HPV-positive cancer cells.

Transdermal prodrug patches deliver treprostinil via passive diffusion through skin layers.

Styrene-based thermoplastic elastomer adhesive prevents peeling on joints by balancing viscosity and cohesive force.

A hydroxypropyl-beta-cyclodextrin inclusion complex encapsulates the active pharmaceutical ingredient KX2-361 to form a stable oral tablet formulation.

Alkynyl substituted quinazolines cross the blood-brain barrier to treat primary brain tumors by providing durable exposure in brain tissue.

Converting the viscous free base into acid addition salts resolves solubility and stability issues for pharmaceutical manufacturing.

Mutant NGAL proteins traffic iron out of the body via urinary excretion, bypassing kidney reabsorption to treat iron overload.

Segmented particles with a gelling core increase viscosity in liquid, hindering parenteral abuse while maintaining immediate release.

Integrating viral vectors express microRNAs in trabecular meshwork cells, eliminating patient compliance issues while maintaining normal eye pressure.

Flavoring agents mask the strong odor of amlodipine besylate to improve palatability, resolving non-compliance in veterinary hypertension treatment.

Oral antioxidants preserve retinal photoreceptors, reducing intravitreal injection frequency for AMD treatment.

Targeting the APRIL-TACI interaction selectively modulates regulatory T and B cells, overcoming tumor immunosuppression without affecting effector T cells.

Form E of Sofosbuvir resolves electrostatic charging issues by maintaining low hygroscopicity and stable polymorphic purity during large-scale preparation.

Dual-targeting siRNA compositions reduce normal cell toxicity and drug resistance by blocking multiple cancer pathways concurrently.

Small molecule compounds block PD-1 interactions, restoring antigen-specific T cell functions and enhancing immune responses against cancer.

Conjugating hydrophobic CC-1065 derivatives with hydrophilic carriers resolves poor water solubility and aggregation while enabling selective tumor delivery.

Merges oncolytic HSV with STAT1/3 inhibitors to overcome macrophage-mediated suppression of viral activity.

High-purity cannabinol compositions reduce sleep disturbances and treat disorders while minimizing side effects like psychomotor deficits.

Genotyping stratifies patients into risk groups, enabling tailored analgesic selection that reduces respiratory depression while maintaining pain relief.

Chiral chromatography using polysaccharide derivatives resolves lenalidomide enantiomers without racemization, enabling accurate pharmacokinetic studies.

A nasal dispensing device uses a conical container bottom to direct pharmaceutical composition toward the dip tube for consistent dosing.